1 | Cancer | 1.14% | |
2 | Study | 1.14% | |
3 | Medicina | 0.91% | |
4 | Pain | 0.91% | |
5 | Health | 0.68% | |
6 | AI | 0.68% | |
7 | Doubling | 0.46% | |
8 | Perceived | 0.46% | |
9 | Age | 0.46% | |
10 | Syndrome | 0.46% | |
11 | Users | 0.46% | |
12 | Genome | 0.46% | |
13 | Clinical | 0.46% | |
14 | Anvisa | 0.46% | |
15 | Risk | 0.46% | |
16 | Moderna | 0.46% | |
17 | India | 0.46% | |
18 | Early | 0.46% | |
19 | May | 0.46% | |
20 | Metastatic | 0.46% | |
21 | Practice | 0.46% | |
22 | Dementia | 0.46% | |
23 | Data | 0.46% | |
24 | Blood | 0.46% | |
25 | MMR | 0.46% | |
26 | Brain | 0.46% | |
27 | Total | 0.46% | |
28 | UK | 0.46% | |
29 | Genetic | 0.46% | |
30 | Immunotherapy | 0.46% | |
31 | Rates | 0.46% | |
32 | HIV | 0.46% | |
33 | Tumors | 0.46% | |
34 | Use | 0.46% | |
35 | Cannabis | 0.46% | |
36 | Mediterranean | 0.23% | |
37 | Canine | 0.23% | |
38 | Women’s | 0.23% | |
39 | Inf | 0.23% | |
40 | Campaigns | 0.23% | |
41 | Split | 0.23% | |
42 | Mexico | 0.23% | |
43 | Chatbot | 0.23% | |
44 | Gut | 0.23% | |
45 | Cryotherapy | 0.23% | |
46 | Allergy | 0.23% | |
47 | $1B | 0.23% | |
48 | Added | 0.23% | |
49 | Cefazolin | 0.23% | |
50 | Doubled | 0.23% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Metastatic Tumors Favor Genome Doubling Over Mutations, Driving Resistance
Inside Precision Medicine
2025-06-02 22:37:34